Viridian Therapeutics, Inc.
221 Crescent St #401,
Waltham, 02453, MA,
United States
Waltham, 02453, MA,
United States
1 617-272-4600
Life Sciences
Viridian Therapeutics, Inc. Technographics
Viridian Therapeutics, Inc. Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Viridian Therapeutics, Inc. and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 80 Viridian Therapeutics, Inc. employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Viridian Therapeutics, Inc. has purchased the following applications: Microsoft 365 for Collaboration in 2021, DocuSign eSignature for Digital Signing in 2021, Salesforce Sales Cloud for Sales Automation, CRM, Sales Engagement in 2022 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Viridian Therapeutics, Inc. is running and its propensity to invest more and deepen its relationship with Microsoft , CodeTwo , DocuSign or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Viridian Therapeutics, Inc. revenues, which have grown to $10.0 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Viridian Therapeutics, Inc. intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Viridian Therapeutics, Inc. Tech Stack and Enterprise Applications
Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Microsoft | Legacy | Microsoft 365 | Collaboration | Collaboration | n/a | 2021 | 2021 |
In 2021, Viridian Therapeutics, Inc. deployed Microsoft 365 as its Collaboration platform. The small United States based life sciences company implemented Microsoft 365 to establish a unified collaboration and productivity environment across the organization.
The Microsoft 365 implementation includes core Collaboration capabilities typical for the category, including Exchange Online email, Microsoft Teams for synchronous communication, SharePoint Online for document management, OneDrive for personal file storage, and Office desktop and web applications for content creation and co authoring. Configuration emphasis was placed on document versioning, shared team workspaces, and centralized mailbox and calendar management to standardize collaboration workflows.
Viridian Therapeutics, Inc. is using Microsoft 365 on their website. The deployment is structured to support corporate, research, and clinical support functions within the United States, centralizing communication channels and document workflows for cross functional teams.
Governance for the Microsoft 365 tenant focuses on tenant level administration, user provisioning and role based access to Teams and SharePoint sites, and application level compliance controls consistent with Collaboration category best practices. Operational practices emphasize managed site templates and controlled external sharing to align collaboration behavior with life sciences information governance requirements.
|
|
|
|
|
Collaboration | Collaboration |
|
2022 | 2022 |
|
Content Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| DocuSign | Legacy | DocuSign eSignature | Digital Signing | Content Management | n/a | 2021 | 2021 |
In 2021 Viridian Therapeutics, Inc. implemented DocuSign eSignature as a Digital Signing solution on its public website. The deployment uses DocuSign eSignature to provide embedded web-based signature capture for externally facing documents, leveraging the cloud-hosted application as a signing layer to support browser-based signing and orchestrated signing workflows.
The implementation is focused on public-facing execution workflows where external signatories interact with site forms and documents, positioning DocuSign eSignature as the digital signature mechanism for those web interactions. Integration is web-centric and emphasizes embedded signing and document delivery to signers, with category-aligned capabilities such as tamper-evident audit trails and secure signature certificates commonly associated with Digital Signing implementations.
|
CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Salesforce | Legacy | Salesforce Sales Cloud | Sales Automation, CRM, Sales Engagement | CRM | n/a | 2022 | 2022 |
In 2022, Viridian Therapeutics, Inc. implemented Salesforce Sales Cloud to support Sales Automation,CRM,Sales Engagement across its commercial and business development functions. The Salesforce Sales Cloud instance is surfaced on the corporate website to capture inbound interest and route leads directly into the CRM for qualification.
The deployment configures core Salesforce Sales Cloud capabilities including lead and contact management, opportunity and pipeline tracking, activity and task management, and sales engagement workflows aligned to biotech business development processes. The Salesforce Sales Cloud environment uses role based profiles, custom page layouts, and record types to reflect the company's commercial and partnership motions. Automation includes web based lead capture, assignment rules, email activity logging, and activity timelines to centralize account and opportunity data.
Operational scope covers sales, business development, and commercial leadership with access and permissions tailored to each function, and revenue operations overseeing pipeline governance and reporting. Governance was implemented through standardized opportunity stages, approval routing for deal progression, and training to embed consistent pipeline hygiene and activity tracking.
|
EPM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Environmental, Social, and Governance (ESG) | EPM |
|
2022 | 2022 |
|
ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
IT Service Management | ITSM |
|
2021 | 2021 |
|
Investment Management
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Portfolio and Investment Management | Investment Management |
|
2023 | 2023 |
|
IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2019 | 2019 |
|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2020 | 2020 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2022 | 2022 |
|
IT Decision Makers and Key Stakeholders at Viridian Therapeutics, Inc.
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
| No data found | ||||||
Apps Being Evaluated by Viridian Therapeutics, Inc. Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Viridian Therapeutics, Inc. IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Viridian Therapeutics, Inc. digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Viridian Therapeutics, Inc. Technographics
Viridian Therapeutics, Inc. is a Life Sciences organization based in United States,
with around 80 employees and annual revenues of $10.0 million.
Viridian Therapeutics, Inc. operates a diverse technology stack with applications such as
Microsoft 365, DocuSign eSignature and Salesforce Sales Cloud,
covering areas like Collaboration, Digital Signing and Sales Automation, CRM, Sales Engagement.
Viridian Therapeutics, Inc. has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Microsoft, DocuSign and Salesforce.
Viridian Therapeutics, Inc. recently adopted applications including
Clearwater Platform in 2023, CodeTwo Email Signatures in 2022 and Salesforce Sales Cloud in 2022,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Viridian Therapeutics, Inc.’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Viridian Therapeutics, Inc.’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Viridian Therapeutics, Inc. technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.